Literature DB >> 8555895

Insidiously evolving, occult drug interaction involving warfarin and amiodarone.

B Cheung1, F M Lam, C R Kumana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8555895      PMCID： PMC2349759          DOI： 10.1136/bmj.312.7023.107

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Side effects of long-term amiodarone therapy.

Authors:  L Harris; W J McKenna; E Rowland; D W Holt; G C Storey; D M Krikler
Journal:  Circulation       Date:  1983-01       Impact factor: 29.690

2.  Dangers of amiodarone and anticoagulant treatment.

Authors:  A Rees; J J Dalal; P G Reid; A H Henderson; M J Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

3.  Interaction between warfarin sodium and amiodarone.

Authors:  U Martinowitz; J Rabinovich; D Goldfarb; A Many; H Bank
Journal:  N Engl J Med       Date:  1981-03-12       Impact factor: 91.245

Review 4.  Pharmacokinetic drug interactions with amiodarone.

Authors:  L J Lesko
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

5.  The mechanism of the interaction between amiodarone and warfarin in humans.

Authors:  L D Heimark; L Wienkers; K Kunze; M Gibaldi; A C Eddy; W F Trager; R A O'Reilly; D A Goulart
Journal:  Clin Pharmacol Ther       Date:  1992-04       Impact factor: 6.875

Review 6.  Clinical pharmacokinetics of amiodarone.

Authors:  R Latini; G Tognoni; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

7.  The potentiation of warfarin anticoagulation by amiodarone.

Authors:  A Hamer; T Peter; W J Mandel; M M Scheinman; D Weiss
Journal:  Circulation       Date:  1982-05       Impact factor: 29.690
  7 in total
  4 in total

1.  The use of wireless laptop computers for computer-assisted learning in pharmacokinetics.

Authors:  Myrna Y Munar; Harleen Singh; Donna Belle; Carolyn C Brackett; Sandra B Earle
Journal:  Am J Pharm Educ       Date:  2006-02-15       Impact factor: 2.047

2.  Monitoring may need to be prolonged in patients given warfarin and amiodarone.

Authors:  B Tomlinson; R P Young; T Y Chan; J A Critchley; J C Chan
Journal:  BMJ       Date:  1996-08-03

3.  The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose.

Authors:  Darja Herman; Igor Locatelli; Iztok Grabnar; Polona Peternel; Mojca Stegnar; Mitja Lainscak; Ales Mrhar; Katja Breskvar; Vita Dolzan
Journal:  Eur J Clin Pharmacol       Date:  2006-03-22       Impact factor: 2.953

4.  Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery.

Authors:  Tomoki Takase; Hiroaki Ikesue; Makiko Tohi; Hiroshi Ueta; Hiroyuki Mima; Tadaaki Koyama; Tohru Hashida
Journal:  J Pharm Health Care Sci       Date:  2018-05-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.